Filtricine (Series A(+))

Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Founders
Grace Yang, Jimmy Wang, Xiyan Li
Company Description
Filtricine, Inc. is a pre-clinical-stage therapeutic company. For cancer patients who want effective, safe, and long-lasting treatment, Filtricine is developing a drug-free cancer therapy based on nutrient deprivation. By precisely taking away the nutrients that are necessary only for cancer cells, the therapy kills only the cancer—not the patient.
Market
Human Health
Location
United States

Links
Back to Home Back to Biopharma Deals View Funding Announcement